TransCanna Holdings Inc. (CSE:TCAN, FSE:TH8) (“TransCanna” or the “Company”) is pleased to announce it has appointed Douglas Mason, founder of Clearly Canadian Beverage Corporation, to the Board of Directors effective today March 18, 2020. Mr. Mason has served as a senior officer and director of public companies and has extensive experience in financings and acquisitions in the capital markets.
Mr. Mason served as President and CEO of Clearly Canadian Beverage Corporation for over 17 years. Clearly Canadian was a producer of premium beverage products. Mr. Mason built the company’s reputation for innovation and he was credited as being one of the pioneers of the New Age Beverage category. He will bring significant depth to TransCanna for growing the business in the retail California marketplace.
“I welcome Douglas to our Board, he brings a depth of experience in the consumer products business in California and the public markets in Canada. The entire team of TransCanna looks forward to his expertise and contributions to the Company” said Steve Giblin President and CEO of TransCanna.
“After proper due diligence I am happy to accept this appointment and look forward to helping where I can as an independent director,” said Mr. Mason. “I see many similarities to TransCanna and when we started Clearly Canadian and looked to California for all its advantages the least of which is the size of their market. The fact that TransCanna’s team is well versed has me quite excited.”
With the appointment of Mr. Mason, the Company has accepted the resignation of Ian Klassen from the Board, Mr. Klassen will remain involved as a member of the company’s Advisory Committee. Additionally, the Company has accepted the resignation of Board member Peter Vitulli.
About TransCanna Holdings Inc.
TransCanna Holdings Inc. is a California based, Canadian listed, company building cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.
On behalf of the Board of Directors
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans, and prospects that constitute forward-looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance of the Company and its subsidiaries may differ materially from those anticipated and indicated by these forward-looking statements. Forward-looking statements in this news release include, but are not limited to: Timing of the expected benefits of Lyfted Farms, Inc. and the Daly Avenue Facility to the Company’s business, regulatory permitting and compliance, changes to regulations affecting the business of the Company or its subsidiaries, achievement of revenue targets, market demand for and associated changes in the demand for the Company’s products, operating costs, as well as general economic, business and political conditions. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/